ENGINEERED INTERLEUKIN-2 RECEPTOR BETA AGONISTS

Fecha de publicación: 05/01/2023
Fuente: WIPO Rice
Provided herein are engineered IL2 polypeptides and fusion proteins thereof. Also provided are methods of modulating an immune response by administering an engineered IL2 polypeptide or a fusion protein thereof. The engineered IL2 polypeptides and fusion proteins thereof demonstrate increased binding to IL2Rβ, decreased binding to IL2Rα, or both.